ViaCell to Present at the UBS 2006 Global Life Sciences Conference

Date : 09/18/2006 @ 9:30AM
Source : PR Newswire
Click here for ADVFN's up to the minute news service. Access our extensive collection of financial news from around the world including US, Europe and Asia.
<< Back

 



ViaCell to Present at the UBS 2006 Global Life Sciences Conference

CAMBRIDGE, Mass., Sept. 18 /PRNewswire-FirstCall/ -- ViaCell, Inc. (NASDAQ:VIAC) today announced that Marc D. Beer, President and Chief Executive Officer of ViaCell, will present an update on its product pipeline and business activities at the UBS 2006 Global Life Sciences Conference on Monday, September 25, 2006 at 4:00 p.m. Eastern Time at the Grand Hyatt Hotel in New York City. A live audio webcast of the presentation will be available on the Investor Information section of the ViaCell website at http://www.viacellinc.com/. A replay of the presentation will be available for approximately three months after the webcast.

ViaCell is a biotechnology company focused on enabling the widespread use of human cells as medicine. The Company is developing a pipeline of proprietary stem cell product candidates intended to address cancer, cardiac disease, and diabetes. CB001, its lead cord blood derived stem cell therapy product candidate, is being developed for hematopoietic stem cell transplantation in patients affected by a variety of cancers. In addition to its therapeutic development programs, ViaCell's reproductive health business commercializes ViaCord(R), a product that offers expecting families the option of preserving their baby's umbilical cord blood. The Company is working to leverage its commercial infrastructure and product development capabilities by developing ViaCyte(SM), its investigational product candidate intended to broaden reproductive choices for women through the cryopreservation of human unfertilized eggs. ViaCell is headquartered in Cambridge, Massachusetts with a processing and storage facility in Kentucky and additional research and development operations in Singapore. Additional information about ViaCell is available online at http://www.viacellinc.com/.

ViaCell(R) and ViaCord(R) are registered trademarks and ViaCyteSM is a service mark of ViaCell, Inc.

For More Information Contact: Justine E. Koenigsberg Senior Director, Corporate Communications (617) 914-3494

http://www.newscom.com/cgi-bin/prnh/20060303/VIACELLLOGO

http://photoarchive.ap.org/

DATASOURCE: ViaCell, Inc.

CONTACT: Justine E. Koenigsberg, Senior Director of Corporate

Communications for ViaCell, +1-617-914-3494

Web site: http://www.viacellinc.com/

<< Back


Viacell (MM) Historical Chart Viacell (MM) Intraday Chart  
Period


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
34 site:2us 081013 20:46 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )